Skip to main content
. 2015 Jun 26;21(2):131–140. doi: 10.3350/cmh.2015.21.2.131

Figure 1. Flow diagram of the study population. LAM, lamivudine; HBV, hepatitis B virus; NA, nucleos(t)ide analogue; HCV, hepatitis C virus; VB, virologic breakthrough.

Figure 1